The Czech expert in the field of drug safety,  Dr. Yan Patrick visited SFDA head office and met H.E. The Chief Executive Officer of SFDA.

 

The two parties discussed, in the presence of the Vice President of Drug Sector, Dr. Ibrahim Al Jufali and the Executive Director of Pharmacovigilence & Crisis Management Department, Dr. Adel Al Harf, the topics of mutual interest in addition to the workshops organized by Pharmacovigilence & Crisis Management Department, focusing  on disclosure of the Pharmacovigilence Signal used by EU Regulatory Authorities via EU Drug Authority & Medical & Health Products Regulatory Authority (MHRA).

​